Related Experiment Video
Updated: Aug 14, 2026

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits
Published on: September 27, 2019
Abstract:
Brown et al. provide a comprehensive evaluation of the public reporting of healthcare performance data, with, however, some limitation on recommendations for its effectiveness. Experience gained over the past 20 years is predominantly in the US with some in the UK. The small amount of Australian experience is reported in this paper. Accountability appears to override quality improvement as the purpose of publishing. It is easier to recount negative effects than positive ones but the overriding finding is the relatively small impression public disclosure has had on healthcare delivery. In an effort to overcome this problem, the intended audience should be clarified and the information correspondingly tailored. For consumers, information should mainly be concerned with issues of process and patient satisfaction, and for the providers, predominantly outcome data.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Methods of Medium Optimization
Pharmacogenomics: Identification of New Drug Targets
Selected Data About Geographic Locations

